Kato et al., Cancer Immunol Immunother 2011
(Carcinoma, Lewis Lung...) :
SAg plus OVA ( 257-264 ) -pulsed DC vaccine strongly enhanced peptide-specific CD8 ( + ) T cells exhibiting OVA ( 257-264 ) -specific cytotoxic activity and IFN-? production, leading to the induction of protective immunity against EG7 tumors
Parra et al., J Immunol 1997
:
This study compares the ability of LFA-3 ( CD58 ) and B7-1 ( CD80 ) ligands to provide costimulatory signals for superantigen (SAg) stimulated CD8+ and CD4+ T cells